IBDEI34S ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50005,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50005,1,3,0)
;;=3^Systemic Sclerosis w/ Polyneuropathy
;;^UTILITY(U,$J,358.3,50005,1,4,0)
;;=4^M34.83
;;^UTILITY(U,$J,358.3,50005,2)
;;=^5011783
;;^UTILITY(U,$J,358.3,50006,0)
;;=M34.89^^193^2487^314
;;^UTILITY(U,$J,358.3,50006,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50006,1,3,0)
;;=3^Systemic Sclerosis NEC
;;^UTILITY(U,$J,358.3,50006,1,4,0)
;;=4^M34.89
;;^UTILITY(U,$J,358.3,50006,2)
;;=^5011784
;;^UTILITY(U,$J,358.3,50007,0)
;;=M34.9^^193^2487^318
;;^UTILITY(U,$J,358.3,50007,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50007,1,3,0)
;;=3^Systemic Sclerosis,Unspec
;;^UTILITY(U,$J,358.3,50007,1,4,0)
;;=4^M34.9
;;^UTILITY(U,$J,358.3,50007,2)
;;=^5011785
;;^UTILITY(U,$J,358.3,50008,0)
;;=R21.^^193^2487^297
;;^UTILITY(U,$J,358.3,50008,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50008,1,3,0)
;;=3^Rash/Nonspecific Skin Eruption
;;^UTILITY(U,$J,358.3,50008,1,4,0)
;;=4^R21.
;;^UTILITY(U,$J,358.3,50008,2)
;;=^5019283
;;^UTILITY(U,$J,358.3,50009,0)
;;=R23.3^^193^2487^309
;;^UTILITY(U,$J,358.3,50009,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50009,1,3,0)
;;=3^Spontaneous Ecchymoses
;;^UTILITY(U,$J,358.3,50009,1,4,0)
;;=4^R23.3
;;^UTILITY(U,$J,358.3,50009,2)
;;=^5019295
;;^UTILITY(U,$J,358.3,50010,0)
;;=L03.113^^193^2487^114
;;^UTILITY(U,$J,358.3,50010,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50010,1,3,0)
;;=3^Cellulitis of Right Upper Limb
;;^UTILITY(U,$J,358.3,50010,1,4,0)
;;=4^L03.113
;;^UTILITY(U,$J,358.3,50010,2)
;;=^5009033
;;^UTILITY(U,$J,358.3,50011,0)
;;=L03.114^^193^2487^107
;;^UTILITY(U,$J,358.3,50011,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50011,1,3,0)
;;=3^Cellulitis of Left Upper Limb
;;^UTILITY(U,$J,358.3,50011,1,4,0)
;;=4^L03.114
;;^UTILITY(U,$J,358.3,50011,2)
;;=^5009034
;;^UTILITY(U,$J,358.3,50012,0)
;;=L03.115^^193^2487^111
;;^UTILITY(U,$J,358.3,50012,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50012,1,3,0)
;;=3^Cellulitis of Right Lower Limb
;;^UTILITY(U,$J,358.3,50012,1,4,0)
;;=4^L03.115
;;^UTILITY(U,$J,358.3,50012,2)
;;=^5009035
;;^UTILITY(U,$J,358.3,50013,0)
;;=L03.116^^193^2487^104
;;^UTILITY(U,$J,358.3,50013,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50013,1,3,0)
;;=3^Cellulitis of Left Lower Limb
;;^UTILITY(U,$J,358.3,50013,1,4,0)
;;=4^L03.116
;;^UTILITY(U,$J,358.3,50013,2)
;;=^5133645
;;^UTILITY(U,$J,358.3,50014,0)
;;=L03.123^^193^2487^28
;;^UTILITY(U,$J,358.3,50014,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50014,1,3,0)
;;=3^Acute Lymphangitis of Right Upper Limb
;;^UTILITY(U,$J,358.3,50014,1,4,0)
;;=4^L03.123
;;^UTILITY(U,$J,358.3,50014,2)
;;=^5009039
;;^UTILITY(U,$J,358.3,50015,0)
;;=L03.124^^193^2487^22
;;^UTILITY(U,$J,358.3,50015,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50015,1,3,0)
;;=3^Acute Lymphangitis of Left Upper Limb
;;^UTILITY(U,$J,358.3,50015,1,4,0)
;;=4^L03.124
;;^UTILITY(U,$J,358.3,50015,2)
;;=^5009040
;;^UTILITY(U,$J,358.3,50016,0)
;;=L03.125^^193^2487^26
;;^UTILITY(U,$J,358.3,50016,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50016,1,3,0)
;;=3^Acute Lymphangitis of Right Lower Limb
;;^UTILITY(U,$J,358.3,50016,1,4,0)
;;=4^L03.125
;;^UTILITY(U,$J,358.3,50016,2)
;;=^5009041
;;^UTILITY(U,$J,358.3,50017,0)
;;=L03.126^^193^2487^20
;;^UTILITY(U,$J,358.3,50017,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI34S 3751 printed Apr 09, 2024@21:28:41 Page 2
IBDEI34S ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50005,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,50005,1,3,0)
+4 ;;=3^Systemic Sclerosis w/ Polyneuropathy
+5 ;;^UTILITY(U,$J,358.3,50005,1,4,0)
+6 ;;=4^M34.83
+7 ;;^UTILITY(U,$J,358.3,50005,2)
+8 ;;=^5011783
+9 ;;^UTILITY(U,$J,358.3,50006,0)
+10 ;;=M34.89^^193^2487^314
+11 ;;^UTILITY(U,$J,358.3,50006,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,50006,1,3,0)
+14 ;;=3^Systemic Sclerosis NEC
+15 ;;^UTILITY(U,$J,358.3,50006,1,4,0)
+16 ;;=4^M34.89
+17 ;;^UTILITY(U,$J,358.3,50006,2)
+18 ;;=^5011784
+19 ;;^UTILITY(U,$J,358.3,50007,0)
+20 ;;=M34.9^^193^2487^318
+21 ;;^UTILITY(U,$J,358.3,50007,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,50007,1,3,0)
+24 ;;=3^Systemic Sclerosis,Unspec
+25 ;;^UTILITY(U,$J,358.3,50007,1,4,0)
+26 ;;=4^M34.9
+27 ;;^UTILITY(U,$J,358.3,50007,2)
+28 ;;=^5011785
+29 ;;^UTILITY(U,$J,358.3,50008,0)
+30 ;;=R21.^^193^2487^297
+31 ;;^UTILITY(U,$J,358.3,50008,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,50008,1,3,0)
+34 ;;=3^Rash/Nonspecific Skin Eruption
+35 ;;^UTILITY(U,$J,358.3,50008,1,4,0)
+36 ;;=4^R21.
+37 ;;^UTILITY(U,$J,358.3,50008,2)
+38 ;;=^5019283
+39 ;;^UTILITY(U,$J,358.3,50009,0)
+40 ;;=R23.3^^193^2487^309
+41 ;;^UTILITY(U,$J,358.3,50009,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,50009,1,3,0)
+44 ;;=3^Spontaneous Ecchymoses
+45 ;;^UTILITY(U,$J,358.3,50009,1,4,0)
+46 ;;=4^R23.3
+47 ;;^UTILITY(U,$J,358.3,50009,2)
+48 ;;=^5019295
+49 ;;^UTILITY(U,$J,358.3,50010,0)
+50 ;;=L03.113^^193^2487^114
+51 ;;^UTILITY(U,$J,358.3,50010,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,50010,1,3,0)
+54 ;;=3^Cellulitis of Right Upper Limb
+55 ;;^UTILITY(U,$J,358.3,50010,1,4,0)
+56 ;;=4^L03.113
+57 ;;^UTILITY(U,$J,358.3,50010,2)
+58 ;;=^5009033
+59 ;;^UTILITY(U,$J,358.3,50011,0)
+60 ;;=L03.114^^193^2487^107
+61 ;;^UTILITY(U,$J,358.3,50011,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,50011,1,3,0)
+64 ;;=3^Cellulitis of Left Upper Limb
+65 ;;^UTILITY(U,$J,358.3,50011,1,4,0)
+66 ;;=4^L03.114
+67 ;;^UTILITY(U,$J,358.3,50011,2)
+68 ;;=^5009034
+69 ;;^UTILITY(U,$J,358.3,50012,0)
+70 ;;=L03.115^^193^2487^111
+71 ;;^UTILITY(U,$J,358.3,50012,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,50012,1,3,0)
+74 ;;=3^Cellulitis of Right Lower Limb
+75 ;;^UTILITY(U,$J,358.3,50012,1,4,0)
+76 ;;=4^L03.115
+77 ;;^UTILITY(U,$J,358.3,50012,2)
+78 ;;=^5009035
+79 ;;^UTILITY(U,$J,358.3,50013,0)
+80 ;;=L03.116^^193^2487^104
+81 ;;^UTILITY(U,$J,358.3,50013,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,50013,1,3,0)
+84 ;;=3^Cellulitis of Left Lower Limb
+85 ;;^UTILITY(U,$J,358.3,50013,1,4,0)
+86 ;;=4^L03.116
+87 ;;^UTILITY(U,$J,358.3,50013,2)
+88 ;;=^5133645
+89 ;;^UTILITY(U,$J,358.3,50014,0)
+90 ;;=L03.123^^193^2487^28
+91 ;;^UTILITY(U,$J,358.3,50014,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,50014,1,3,0)
+94 ;;=3^Acute Lymphangitis of Right Upper Limb
+95 ;;^UTILITY(U,$J,358.3,50014,1,4,0)
+96 ;;=4^L03.123
+97 ;;^UTILITY(U,$J,358.3,50014,2)
+98 ;;=^5009039
+99 ;;^UTILITY(U,$J,358.3,50015,0)
+100 ;;=L03.124^^193^2487^22
+101 ;;^UTILITY(U,$J,358.3,50015,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,50015,1,3,0)
+104 ;;=3^Acute Lymphangitis of Left Upper Limb
+105 ;;^UTILITY(U,$J,358.3,50015,1,4,0)
+106 ;;=4^L03.124
+107 ;;^UTILITY(U,$J,358.3,50015,2)
+108 ;;=^5009040
+109 ;;^UTILITY(U,$J,358.3,50016,0)
+110 ;;=L03.125^^193^2487^26
+111 ;;^UTILITY(U,$J,358.3,50016,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,50016,1,3,0)
+114 ;;=3^Acute Lymphangitis of Right Lower Limb
+115 ;;^UTILITY(U,$J,358.3,50016,1,4,0)
+116 ;;=4^L03.125
+117 ;;^UTILITY(U,$J,358.3,50016,2)
+118 ;;=^5009041
+119 ;;^UTILITY(U,$J,358.3,50017,0)
+120 ;;=L03.126^^193^2487^20
+121 ;;^UTILITY(U,$J,358.3,50017,1,0)
+122 ;;=^358.31IA^4^2
